Healthcare provider profile · identity verified

William E Burt, MD

Family Practice · NEW PORT RICHEY, FL · NPI 1154542926

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	200	34
Levothyroxine Sodium	Levothyroxine Sodium	180	29
Atorvastatin Calcium	Atorvastatin Calcium	171	42
Amlodipine Besylate	Amlodipine Besylate	139	24
Tamsulosin Hcl	Tamsulosin Hcl	130	21
Pantoprazole Sodium	Pantoprazole Sodium	128	26
Losartan Potassium	Losartan Potassium	127	19
Rosuvastatin Calcium	Rosuvastatin Calcium	121	21
Eliquis	Apixaban	119	22
Furosemide	Furosemide	117	26
Metoprolol Succinate	Metoprolol Succinate	115	24
Clopidogrel	Clopidogrel Bisulfate	112	18
Potassium Chloride	Potassium Chloride	107	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	17
Omeprazole	Omeprazole	96	19
Famotidine	Famotidine	92	19
Topiramate	Topiramate	92	suppressed
Memantine Hcl	Memantine Hcl	88	16
Donepezil Hcl	Donepezil Hcl	85	14
Metformin Hcl	Metformin Hcl	84	18
Bumetanide	Bumetanide	77	suppressed
Montelukast Sodium	Montelukast Sodium	74	17
Duloxetine Hcl	Duloxetine Hcl	68	11
Metoprolol Tartrate	Metoprolol Tartrate	68	16
Lorazepam	Lorazepam	64	19
Allopurinol	Allopurinol	62	suppressed
Trazodone Hcl	Trazodone Hcl	60	15
Spironolactone	Spironolactone	59	suppressed
Prednisone	Prednisone	58	suppressed
Sertraline Hcl	Sertraline Hcl	58	13
Warfarin Sodium	Warfarin Sodium	49	suppressed
Pregabalin	Pregabalin	46	12
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	45	suppressed
Bupropion Hcl Sr	Bupropion Hcl	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	11
Breyna	Budesonide/Formoterol Fumarate	42	suppressed
Divalproex Sodium	Divalproex Sodium	42	12
Morphine Sulfate Er	Morphine Sulfate	42	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Carvedilol	Carvedilol	39	14
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Lamotrigine	Lamotrigine	37	suppressed
Clonazepam	Clonazepam	35	suppressed
Lisinopril	Lisinopril	35	13
Midodrine Hcl	Midodrine Hcl	35	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	11
Buspirone Hcl	Buspirone Hcl	34	suppressed
Finasteride	Finasteride	34	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Baclofen	Baclofen	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Nuplazid	Pimavanserin Tartrate	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Alogliptin	Alogliptin Benzoate	27	suppressed
Olanzapine	Olanzapine	26	suppressed
Torsemide	Torsemide	26	suppressed
Mirabegron Er	Mirabegron	25	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Primidone	Primidone	21	suppressed
Risperidone	Risperidone	21	suppressed
Anastrozole	Anastrozole	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Nystatin	Nystatin	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Temazepam	Temazepam	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Liraglutide	Liraglutide	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	12	suppressed
Atenolol	Atenolol	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methimazole	Methimazole	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Renvela	Sevelamer Carbonate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error